PDS Biotechnology Corp·4

Jun 7, 5:46 PM ET

WOOD LAUREN 4

4 · PDS Biotechnology Corp · Filed Jun 7, 2019

Insider Transaction Report

Form 4
Period: 2019-06-06
WOOD LAUREN
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right To Purchase)

    2019-06-06+62,71562,715 total
    Exercise: $6.39Exp: 2029-06-06Common Stock (62,715 underlying)
Footnotes (1)
  • [F1]This option, representing a right to purchase a total of 62,715 shares of Common Stock, will become exercisable on June 6, 2020, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY